TB research requires strong protections, innovation, and increased funding in response to COVID-19.
B T Nyang'wa, A N LaHood, C D Mitnick, L Guglielmetti
Author Information
- B T Nyang'wa: Manson Unit, Médecins Sans Frontières, London, UK.
- A N LaHood: Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA.
- C D Mitnick: Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA. carole_mitnick@hms.harvard.edu. ORCID
- L Guglielmetti: Médecins Sans Frontières, Paris, France.
No abstract text available.
- Eur Respir J. 2020 Aug 6;56(2):
[PMID: 32513783]
- Eur Respir J. 2020 Jul 9;56(1):
[PMID: 32444399]
- Lancet Glob Health. 2016 Nov;4(11):e806-e815
[PMID: 27720688]
- Eur Respir J. 2021 Jan 5;57(1):
[PMID: 33184119]
- Trop Med Infect Dis. 2020 May 27;5(2):
[PMID: 32471274]
- J Infect Dis. 2012 May 15;205 Suppl 2:S241-9
[PMID: 22448022]
- JAMA. 2020 Jul 7;324(1):33-34
[PMID: 32463422]
- Eur Respir J. 2020 Aug 13;56(2):
[PMID: 32513784]
Biomedical Research
COVID-19
Humans
SARS-CoV-2
